InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by Takanashi Ken. Officer active across 3 companies, notably Satsuma Pharmaceuticals, Inc.. In total, 6 reports have been published. Split: 1 buy · 2 sells. Total volume traded: €18.8m. History available since 6 June 2023. The latest transaction was disclosed on 11 August 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations
TAKANASHI KEN is a Director of Wave Life Sciences Ltd. (XNAS) and Satsuma Pharmaceuticals, Inc. (XNAS). Across 5 filings in total, the recent filings we hold cover the period from 2023-06-08 to 2026-03-26, with EUR 18759272 of buys and EUR 36816 of sells, and the stated transaction nature is Attribution.